Article

Measuring Contrast Variations in MS Lesions

Quantitative susceptibility plus R2* mapping


 

References

Combining quantitative susceptibility mapping (QSM) with R2* mapping is useful for characterizing heterogeneity in multiple sclerosis (MS) lesions, according to a study of 306 MS lesions from 24 MS patients who underwent 7T MRI.

Investigators calculated maps of R2*, frequency, and qualitative susceptibility using acquired multiecho gradient echo (GRE) phase data and found:

• 93% of lesions showed hypointensity on R2*.

• Susceptibility contrast in lesions varied with 40% being isointense and 58% hyperintense in the lesion core.

• Correlations between R2* and susceptibility were found in hyperintense lesions but not in isointense ones.

• 74% of periventricular, 53% of subcortical, and 38% of juxtacortical lesions were found to be susceptibility hyperintense.

Citation: Li X, Harrison DM, Liu H, et al. Magnetic susceptibility contrast variations in multiple sclerosis lesions. J Magn Reson Imaging. 2015. doi: 10.1002/jmri.24976. [Epub ahead of print]

Recommended Reading

Cervical Cord Atrophy in CIS and RRMS
MDedge Neurology
Weight in Adolescence Correlates to Age of MS Diagnosis
MDedge Neurology
Information Processing Differs by Age of MS Diagnosis
MDedge Neurology
Depression, Anxiety, and Multiple Sclerosis
MDedge Neurology
Can MS Progression be Predicted?
MDedge Neurology
Only moderate-quality evidence supports medical cannabinoids
MDedge Neurology
Adherence to MS treatments lower in oral vs. injectable drugs
MDedge Neurology
Optimizing treatment selection in MS often tricky
MDedge Neurology
MS Survival and Comorbidities
MDedge Neurology
Abundance of agents adds choice in choosing MS therapy
MDedge Neurology